GlassScriptPhysician profile
Edward A Hubach
NPI 1821091331
$1,437.95
in general payments reported to CMS, 2019-2025
18 companies · $23.69 in 2025
The $23.69 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $248 · 2021: $477 · 2022: $372 · 2025: $23.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $406.50 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $141.53 | 2019-2022 | |
| Glaxosmithkline, LLC. | $127.35 | 2019-2022 | |
| Novo Nordisk INC | $116.70 | 2019-2022 | |
| Amarin Pharma, INC. | $96.00 | 2019-2021 | |
| Allergan, INC. | $89.59 | 2019-2020 | |
| Pfizer INC. | $80.04 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $60.79 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $57.89 | 2019-2021 | |
| Amgen INC. | $54.03 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.08 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $38.21 | 2019-2021 | |
| Astellas Pharma US INC | $31.58 | 2020-2021 | |
| Lilly USA, LLC | $23.94 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $23.53 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $21.47 | 2022 | |
| Zyla Life Sciences, INC. | $15.74 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Hubach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.